- Home
- PRTA vs GFR Comparison
PRTA vs GFR Comparison
Compare PRTA & GFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- GFR
- Stock Information
- Founded
- PRTA 2012
- GFR 2018
- Country
- PRTA Ireland
- GFR Canada
- Employees
- PRTA N/A
- GFR N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- GFR
- Sector
- PRTA Health Care
- GFR
- Exchange
- PRTA Nasdaq
- GFR Nasdaq
- Market Cap
- PRTA 472.1M
- GFR 318.9M
- IPO Year
- PRTA N/A
- GFR N/A
- Fundamental
- Price
- PRTA $8.20
- GFR $5.25
- Analyst Decision
- PRTA Buy
- GFR
- Analyst Count
- PRTA 10
- GFR 0
- Target Price
- PRTA $14.86
- GFR N/A
- AVG Volume (30 Days)
- PRTA 1.2M
- GFR 42.0K
- Earning Date
- PRTA 08-04-2025
- GFR 08-06-2025
- Dividend Yield
- PRTA N/A
- GFR N/A
- EPS Growth
- PRTA N/A
- GFR N/A
- EPS
- PRTA N/A
- GFR 2.05
- Revenue
- PRTA $10,341,000.00
- GFR $516,308,125.00
- Revenue This Year
- PRTA N/A
- GFR N/A
- Revenue Next Year
- PRTA $389.77
- GFR $27.03
- P/E Ratio
- PRTA N/A
- GFR $2.52
- Revenue Growth
- PRTA N/A
- GFR N/A
- 52 Week Low
- PRTA $4.32
- GFR $3.81
- 52 Week High
- PRTA $22.83
- GFR $8.16
- Technical
- Relative Strength Index (RSI)
- PRTA 58.73
- GFR 67.48
- Support Level
- PRTA $8.05
- GFR $4.14
- Resistance Level
- PRTA $8.73
- GFR $5.01
- Average True Range (ATR)
- PRTA 0.38
- GFR 0.25
- MACD
- PRTA -0.05
- GFR 0.07
- Stochastic Oscillator
- PRTA 47.62
- GFR 97.96
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About GFR Greenfire Resources Ltd.
Greenfire Resources Ltd explores, acquires, develops and produces oil and gas in the Canadian energy sector and internationally. Greenfire currently has two producing oil sand assets, Hangingstone Expansion and Hangingstone Demo. The Company has one reportable operating segment which is made up of its oil sands operations based on geographic location : Athabasca oil sands region of Alberta, Canada, nature of the products sold and integration of facilities and operations.